GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results
- Posted on February 27, 2025
- By Google News
- 1 Views
GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commerciali
